Asthma Flashcards
Pathologic increase in the bronchoconstrictor response to antigens and irritants
Caused by bronchial inflammation
Bronchial hyperreactivity
Phosphodiesterase (PDE)
Enzymes that degrades cAMP (active) to AMP (inactive)
Tacyhphylaxis
Rapid loss of responsiveness to a stimulus (e.g. drug)
Asthma Diagnosis
- Airflow obstruction
- Reversibility of airflow obstruction
- Prolonged expiration and diffuse wheezes
- LIMITATION OF AIRFLOW on PFTs or bronchoprovocation challenge
What is drug therapy aimed to target?
- Narrow airway
- Tightened muscles
- Inflammation
What are the asthma treatment goals?
- Prevent bronchoconstriction-early phase, rescue
- Reduce inflammation- Late/Chronic phase, controller
- Prevent irritant reaction (IgE)- Late/Chronic phase
What drugs target early response phase (bronchoconstriction)?
- Beta agonists
- Theophylline
- Muscarinic antagonists
- Leukotriene antagonist
What drugs target late response phase (inflammation)?
- Steroids
- Cromolyn
- Leukotriene antagonists
What is the ultimate goal in drug therapy?
Relax bronchial tone
Beta Agonists MOA
Stimulate adenylyl cyclase (AC)
Increases cAMP in smooth muscle cells
Bronchodilator response
When would you use Albuterol (Short acting beta agonist )?
Acute asthma–>Rescue
When would you use Salmeterol (long acting beta agonist)?
Asthma proyphlaxis
COPD
Albuterol SEs
Tremor
Tachycardia
Salmeterol SEs
Tremor
Tachycardia
CV events
Lists antimuscarinic agents
Ipatropium
Tiotropium
antimuscarinic agents MOA
Competitively block muscarinic receptors
Prevent bronchoconstriction mediated by vagal discharge
When would you use antimuscarinic agents?
Asthma
COPD
antimuscarinic agents SEs
Dry mouth
Cough
What is unique about antimuscarinic agents?
REVERSE bronchoconstriction in some asthma pt’s (esp. children)
AND in COPD pt’s